122 related articles for article (PubMed ID: 19056322)
1. Intraoperative seed placement for thoracic malignancy-A review of technique, indications, and published literature.
Stewart AJ; Mutyala S; Holloway CL; Colson YL; Devlin PM
Brachytherapy; 2009; 8(1):63-9. PubMed ID: 19056322
[TBL] [Abstract][Full Text] [Related]
2. Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung.
Trombetta MG; Colonias A; Makishi D; Keenan R; Werts ED; Landreneau R; Parda DS
Brachytherapy; 2008; 7(1):50-4. PubMed ID: 18299113
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer.
Johnson M; Colonias A; Parda D; Trombetta M; Gayou O; Reitz B; Miften M
Phys Med Biol; 2007 Mar; 52(5):1237-45. PubMed ID: 17301451
[TBL] [Abstract][Full Text] [Related]
4. Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.
Mutyala S; Stewart A; Khan AJ; Cormack RA; O'Farrell D; Sugarbaker D; Devlin PM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1114-20. PubMed ID: 19540065
[TBL] [Abstract][Full Text] [Related]
5. Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer.
Odell DD; Kent MS; Fernando HC
Semin Thorac Cardiovasc Surg; 2010; 22(1):32-7. PubMed ID: 20813314
[TBL] [Abstract][Full Text] [Related]
6. Sublobar resections for lung cancer.
Fields RC; Meyers BF
Semin Thorac Cardiovasc Surg; 2006; 18(2):85-91. PubMed ID: 17157225
[TBL] [Abstract][Full Text] [Related]
7. CT-guided permanent brachytherapy for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC).
Martínez-Monge R; Pagola M; Vivas I; López-Picazo JM
Lung Cancer; 2008 Aug; 61(2):209-13. PubMed ID: 18243409
[TBL] [Abstract][Full Text] [Related]
8. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.
Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook J
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):61-8. PubMed ID: 18823713
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin: a pilot study.
Nori D; Li X; Pugkhem T
J Surg Oncol; 1995 Dec; 60(4):257-61. PubMed ID: 8551736
[TBL] [Abstract][Full Text] [Related]
10. Severe toxicity after permanent radioactive seed implantation for mediastinal carcinoid tumors.
Stewart AJ; O'Farrell DA; Mutyala S; Bueno R; Sugarbaker DJ; Cormack RA; Devlin PM
Brachytherapy; 2007; 6(1):58-61. PubMed ID: 17284388
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for permanent prostate brachytherapy with (131)Cs: a consensus report from the Cesium Advisory Group.
Bice WS; Prestidge BR; Kurtzman SM; Beriwal S; Moran BJ; Patel RR; Rivard MJ;
Brachytherapy; 2008; 7(4):290-6. PubMed ID: 18782682
[TBL] [Abstract][Full Text] [Related]
12. Placement of 125I implants with the da Vinci robotic system after video-assisted thoracoscopic wedge resection: a feasibility study.
Pisch J; Belsley SJ; Ashton R; Wang L; Woode R; Connery C
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):928-32. PubMed ID: 15465211
[TBL] [Abstract][Full Text] [Related]
13. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
14. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.
Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D
Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric evaluation of radiation exposure during I-125 vicryl mesh implants: implications for ACOSOG z4032.
Smith RP; Schuchert M; Komanduri K; Burton S; Heron DE; Luketich JD; d'Amato T; Landreneau R
Ann Surg Oncol; 2007 Dec; 14(12):3610-3. PubMed ID: 17909906
[TBL] [Abstract][Full Text] [Related]
16. In vivo dosimetry with a linear MOSFET array to evaluate the urethra dose during permanent implant brachytherapy using iodine-125.
Bloemen-van Gurp EJ; Haanstra BK; Murrer LH; van Gils FC; Dekker AL; Mijnheer BJ; Lambin P
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1266-72. PubMed ID: 19665317
[TBL] [Abstract][Full Text] [Related]
17. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
[TBL] [Abstract][Full Text] [Related]
18. Three-times daily radiotherapy after chemotherapy in stage III non-small cell lung cancer. Single-institution prospective study.
Catalano G; De Pas T; Spaggiari L; Gandini S; Jereczek-Fossa BA; De Braud F; Leo F; Veronesi G; Orecchia R
Anticancer Res; 2008; 28(6B):4121-7. PubMed ID: 19192671
[TBL] [Abstract][Full Text] [Related]
19. Radiation dose escalation by percutaneous interstitial brachytherapy in locally advanced non-small cell lung cancer.
Sharma DN; Bahl A; Thulkar S; Rath GK; Basu KS; Bansal A; Julka PK
Indian J Chest Dis Allied Sci; 2009; 51(2):103-6. PubMed ID: 19445446
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
